Clinical ExpressPoints: Emerging Strategies To Optimize Therapeutic Benefit in Advanced Gastrointestinal and Lung Cancers

Download this short slideset of essential highlights from a live presentation on the latest updates in GI and Lung cancers and strategies to optimize outcomes from anticancer therapy
person default
Mary Jo Fidler, MD
John L. Marshall, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 609 KB
Released: July 13, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an independent grant from
Helsinn Healthcare SA

Related Content

In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for ALL

Renier J. Brentjens, MD, PhD Released: December 3, 2020

In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for lymphomas

Frederick L. Locke, MD Released: December 3, 2020

In this slideset from Clinical Care Options, experts provide insights on emerging CAR T-cell strategies for myeloma.

Noopur Raje, MD Released: December 3, 2020

Download this brief slideset for a review of the latest clinical data informing optimal treatment of relapsed ES-SCLC, from Clinical Care Options (CCO)

person default Benjamin Levy, MD Released: December 1, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue